ITRM20070394A1 - Liposomi asimmetrici e loro usi in campo medico. - Google Patents

Liposomi asimmetrici e loro usi in campo medico.

Info

Publication number
ITRM20070394A1
ITRM20070394A1 IT000394A ITRM20070394A ITRM20070394A1 IT RM20070394 A1 ITRM20070394 A1 IT RM20070394A1 IT 000394 A IT000394 A IT 000394A IT RM20070394 A ITRM20070394 A IT RM20070394A IT RM20070394 A1 ITRM20070394 A1 IT RM20070394A1
Authority
IT
Italy
Prior art keywords
liposomas
asymmetric
medical field
medical
field
Prior art date
Application number
IT000394A
Other languages
English (en)
Inventor
Spirito Marco De
Maurizio Fraziano
Emanuela Greco
Gianluca Quintiliani
Original Assignee
Uni Cattolica Del Sacro Cuo Re
Uni Degli Studi Di Roma To R V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Cattolica Del Sacro Cuo Re, Uni Degli Studi Di Roma To R V filed Critical Uni Cattolica Del Sacro Cuo Re
Priority to IT000394A priority Critical patent/ITRM20070394A1/it
Priority to PCT/IT2008/000474 priority patent/WO2009011007A2/en
Priority to AU2008277235A priority patent/AU2008277235A1/en
Priority to EP08790061A priority patent/EP2178602A2/en
Priority to US12/667,257 priority patent/US20100178330A1/en
Priority to MX2010000471A priority patent/MX2010000471A/es
Publication of ITRM20070394A1 publication Critical patent/ITRM20070394A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000394A 2007-07-16 2007-07-16 Liposomi asimmetrici e loro usi in campo medico. ITRM20070394A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT000394A ITRM20070394A1 (it) 2007-07-16 2007-07-16 Liposomi asimmetrici e loro usi in campo medico.
PCT/IT2008/000474 WO2009011007A2 (en) 2007-07-16 2008-07-15 Asymmetric liposomes and uses in medical field thereof
AU2008277235A AU2008277235A1 (en) 2007-07-16 2008-07-15 Asymmetric liposomes and uses in medical field thereof
EP08790061A EP2178602A2 (en) 2007-07-16 2008-07-15 Asymmetric liposomes and uses in medical field thereof
US12/667,257 US20100178330A1 (en) 2007-07-16 2008-07-15 Asymmetric liposomes and uses in medical field thereof
MX2010000471A MX2010000471A (es) 2007-07-16 2008-07-15 Liposomas asimetricas y usos de las mismas en el campo medico.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000394A ITRM20070394A1 (it) 2007-07-16 2007-07-16 Liposomi asimmetrici e loro usi in campo medico.

Publications (1)

Publication Number Publication Date
ITRM20070394A1 true ITRM20070394A1 (it) 2009-01-17

Family

ID=40260195

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000394A ITRM20070394A1 (it) 2007-07-16 2007-07-16 Liposomi asimmetrici e loro usi in campo medico.

Country Status (6)

Country Link
US (1) US20100178330A1 (it)
EP (1) EP2178602A2 (it)
AU (1) AU2008277235A1 (it)
IT (1) ITRM20070394A1 (it)
MX (1) MX2010000471A (it)
WO (1) WO2009011007A2 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011518124A (ja) * 2008-03-26 2011-06-23 ユニバーシティ・オブ・オックスフォード 小胞体ターゲッティングリポソーム
CN102427804A (zh) 2009-03-27 2012-04-25 牛津大学之校长及学者 降低胆固醇水平的脂质体
WO2014061016A1 (en) * 2012-10-15 2014-04-24 Yeda Research And Development Co. Ltd. Use of sphingoid long chain bases and their analogs in treating and preventing bacterial infections
EP3285874B1 (en) * 2015-04-22 2021-03-17 Matinas BioPharma Nanotechnologies, Inc. Compositions and methods for treating mycobacteria infections and lung disease
IL260690A (en) 2018-07-19 2018-12-31 Yeda Res & Dev Sphingosine derivatives and their use against pulmonary bacterial infections
IT202200016401A1 (it) 2022-08-02 2024-02-02 Biolt S R L S Liposoma comprendente fosfatidilserina, acido fosfatidico ed opzionalmente colesterolo, composizione e uso medico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624011A5 (it) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
CA2319928A1 (en) * 2000-09-18 2002-03-18 Vasogen Ireland Limited Apoptosis-mimicking synthetic entities and use thereof in medical treatments
WO2003024422A1 (en) * 2001-09-18 2003-03-27 Vasogen Ireland Limited Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities

Also Published As

Publication number Publication date
EP2178602A2 (en) 2010-04-28
US20100178330A1 (en) 2010-07-15
AU2008277235A1 (en) 2009-01-22
WO2009011007A2 (en) 2009-01-22
WO2009011007A3 (en) 2009-03-19
MX2010000471A (es) 2010-06-02

Similar Documents

Publication Publication Date Title
BRPI0915299A2 (pt) poliamida, composição compreendendo tal poliamida e utilização das mesmas
BRPI0821276A2 (pt) Produto, e, uso do produto
BRPI0820379A2 (pt) Sistemas e métodos de dispensação de produto médico
BRPI0808098A2 (pt) 4-aril-1,4-di-hidro-1,6-naftiridinamidas substituídas e seu uso
BRPI0718182A2 (pt) Oligorribonucleotídeos e seus usos.
HRP20171612T2 (hr) Umrežujuće spojnice i njihova upotreba
BRPI0908864A2 (pt) formas da rifaximina e usos das mesmas
BRPI0910925A2 (pt) conjuntos de transferência de líquido e métodos relacionados
BRPI0815773A2 (pt) composto, e, medicamento.
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
BRPI0812264A2 (pt) Vesícula, e, preparação externa para pele
FI20075881A0 (fi) Lääketieteellinen väline ja sen käyttö
BRPI1010549A2 (pt) dispositivo de campo, e, fluxímetro magnético.
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
ITMI20080027A1 (it) Combinazione biocida per impiego in campo agricolo
BRPI0913175A2 (pt) artigo antibalístico, e, uso do mesmo.
IT1399793B1 (it) Procedimento di preparazione di una biomassa comprendente plantaricina e suoi usi in campo medico.
EP2148272A4 (en) CALCULATION UNIT, PROCESSOR AND PROCESSOR ARCHITECTURE
ITRM20070394A1 (it) Liposomi asimmetrici e loro usi in campo medico.
EP2733960A4 (en) ULTRASONIC ELEMENT AND ULTRASOUND DOSCOPE
DK2310383T3 (da) 2-oxo-alkyl-1-piperazin-2-onderivater, fremstilling deraf og terapeutisk anvendelse deraf
DK2370046T3 (da) Lægemiddeldispenser og anvendelse heraf
IT1398768B1 (it) Uso di microrna-199b-5p in campo medico e diagnostico.
EP2345660A4 (en) ANTI-XDR-TB-MEDIUM, ANTI-MDR-TB-MEDIUM AND COMBINED ANTIBODY CLOUD
DK2154144T3 (da) Oligonukleotider og anvendelse deraf